Erik H J Danen (Erik H Danen, Erik Hj Danen)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Breast Cancer Cells

Top Venues

International journal of molecular sciences

Breast cancer research and treatment

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Chen-Yi Liao, Patrick Engelberts, Andreea Ioan-Facsinay, Janna Eleonora Klip, Thomas Schmidt, Rob Ruijtenbeek, Erik H J Danen
CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing. Communications biology 7 (1) (2024)
Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers, Daphne Roelofs, Kim Kroese, Mieke M Timmermans, Chen-Yi Liao, Shaozhuo Huang, Anita Trapman-Jansen, Renee Foekens, Justine Michaux, Monique T A de Beijer, Sonja I Buschow, Jeroen A A Demmers, Marleen Kok, Erik H J Danen, Michal Bassani-Sternberg, John W M Martens, Rachel J M Abbott, Reno Debets
TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer. Cancer discovery (2024)
Chen-Yi Liao, Patrick Engelberts, Andreea Ioan-Facsinay, Janna Eleonora Klip, Thomas Schmidt, Rob Ruijtenbeek, Erik H J Danen
CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing. Communications biology 7 (1) (2024)
Chen-Yi Liao, Patrick Engelberts, Andreea Ioan-Facsinay, Janna Eleonora Klip, Thomas Schmidt, Rob Ruijtenbeek, Erik H J Danen
CD3-engaging bispecific antibodies trigger a paracrine regulated wave of T-cell recruitment for effective tumor killing. Communications biology 7 (1) (2024)
Qiuyu Liu, Nasi Liu, Vera E van der Noord, Wanda van der Stel, Bob van de Water, Erik H J Danen, Sylvia E Le Dévédec
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia. Breast cancer research and treatment 198 (3) (2023)
Zi Wang, Bircan Coban, Chen-Yi Liao, Yao-Jun Chen, Qiuyu Liu, Erik H J Danen
GRHL2 Regulation of Growth/Motility Balance in Luminal versus Basal Breast Cancer. International journal of molecular sciences 24 (3) (2023)
Zi Wang, Bircan Coban, Chen-Yi Liao, Yao-Jun Chen, Qiuyu Liu, Erik H J Danen
GRHL2 Regulation of Growth/Motility Balance in Luminal versus Basal Breast Cancer. International journal of molecular sciences 24 (3) (2023)
Zi Wang, Bircan Coban, Chen-Yi Liao, Yao-Jun Chen, Qiuyu Liu, Erik H J Danen
GRHL2 Regulation of Growth/Motility Balance in Luminal versus Basal Breast Cancer. International journal of molecular sciences 24 (3) (2023)
Qiuyu Liu, Nasi Liu, Vera E van der Noord, Wanda van der Stel, Bob van de Water, Erik H J Danen, Sylvia E Le Dévédec
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia. Breast cancer research and treatment 198 (3) (2023)
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, Giulia Mantini, Fatemeh Khojasteh-Leylakoohi, Annalisa Comandatore, Ghazaleh Khalili-Tanha, Alireza Khooei, Luca Morelli, Soodabeh Shahidsales, Erik H J Danen, Thomas Schmidt, Elisa Giovannetti
Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC). Cancers 15 (3) (2023)
Zi Wang, Bircan Coban, Chen-Yi Liao, Yao-Jun Chen, Qiuyu Liu, Erik H J Danen
GRHL2 Regulation of Growth/Motility Balance in Luminal versus Basal Breast Cancer. International journal of molecular sciences 24 (3) (2023)
Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, Giulia Mantini, Fatemeh Khojasteh-Leylakoohi, Annalisa Comandatore, Ghazaleh Khalili-Tanha, Alireza Khooei, Luca Morelli, Soodabeh Shahidsales, Erik H J Danen, Thomas Schmidt, Elisa Giovannetti
Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC). Cancers 15 (3) (2023)
Qiuyu Liu, Nasi Liu, Vera E van der Noord, Wanda van der Stel, Bob van de Water, Erik H J Danen, Sylvia E Le Dévédec
Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia. Breast cancer research and treatment (2023)
Qiuyu Liu, Wanda van der Stel, Vera E van der Noord, Hanneke Leegwater, Bircan Coban, Kim Elbertse, Joannes T M Pruijs, Olivier J M Béquignon, Gerard van Westen, Sylvia E Le Dévédec, Erik H J Danen
Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells. International journal of molecular sciences 23 (17) (2022)
Qiuyu Liu, Victoria A C Palmgren, Erik H J Danen, Sylvia E Le Dévédec
Acute vs. chronic vs. intermittent hypoxia in breast Cancer: a review on its application in in vitro research. Molecular biology reports 49 (11) (2022)
Chenlin Feng, Xuesong Wang, Willem Jespers, Rongfang Liu, Sofía Denise Zamarbide Losada, Marina Gorostiola González, Gerard van Westen, Erik H J Danen, Laura H Heitman
Cancer-Associated Mutations of the Adenosine A 2A Receptor Have Diverse Influences on Ligand Binding and Receptor Functions. Molecules (Basel, Switzerland) 27 (15) (2022)
Yasmin Dekker, Sylvia E Le Dévédec, Erik H J Danen, Qiuyu Liu
Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer. Genes 13 (9) (2022)
Josephine Görte, Elke Beyreuther, Erik H J Danen, Nils Cordes
Correction: Görte et al. Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancreatic Cancer Cultures. Cancers 2020, 12, 3216. Cancers 13 (13) (2021)
Wanda van der Stel, Huan Yang, Nanette G Vrijenhoek, Johannes P Schimming, Giulia Callegaro, Giada Carta, Salihanur Darici, Johannes Delp, Anna Forsby, Andrew White, Sylvia E Le Dévédec, Marcel Leist, Paul Jennings, Joost B Beltman, Bob van de Water, Erik H J Danen
Mapping the cellular response to electron transport chain inhibitors reveals selective signaling networks triggered by mitochondrial perturbation. Archives of toxicology (2021)
Sanne Venneker, Alwine B Kruisselbrink, Zuzanna Baranski, Ieva Palubeckaite, Inge H Briaire-de Bruijn, Jan Oosting, Pim J French, Erik H J Danen, Judith V M G Bovée
Beyond the Influence of IDH Mutations: Exploring Epigenetic Vulnerabilities in Chondrosarcoma. Cancers 12 (12) (2020)
Josephine Görte, Elke Beyreuther, Erik H J Danen, Nils Cordes
Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancreatic Cancer Cultures. Cancers 12 (11) (2020)
Sanne Venneker, Alwine B Kruisselbrink, Inge H Briaire-de Bruijn, Yvonne de Jong, Andre J van Wijnen, Erik H J Danen, Judith V M G Bovée
Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status. Cancers 11 (12) (2019)
Tijmen H Booij, Leo S Price, Erik H J Danen
3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis. SLAS discovery : advancing life sciences R & D 24 (6) (2019)